UMass Medical School

hES  Cell Line: HUES-5
Genotyping   Subclones   Publications   User Comments    
Summary   Derivation   Provider   Characteristics Differentiation   Markers   HLA Typing    
 
Gender:
Female
Karyotype:
Abnormal, 46XX, Inv9
Pluripotency Tested:
In vitro, in vivo
Cowan, 2004

Available (Research Grade):
HSCI iPS Core Facility

Eligible for Funding:
NIH
PROVIDER RESTRICTIONS: HUES line recipients must provide documentation of ESCRO (or equivalent ethical) review for the research planned with the requested lines to Harvard University. NIH RESTRICTIONS: NIH-funded research with this line is limited to research consistent with the following language from the informed consent document: "These cells will be used to study the embryonic development of endoderm with a focus on pancreatic formation. The long-term goal is to create human pancreatic islets that contain ß cells, the cells that produce insulin, for transplantation into diabetics."

Number of Publications:
11
Back